Phenindamine hydrogen tartrate
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313433This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19N.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 28725X3PV8, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridine tartrate, but more generally known as phenindamine hydrogen tartrate, which bears US NIH Compound Identifier 11290. European Medicines Agency schedules phenindamine hydrogen tartrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09764MIG. Most nations, for tariff purposes, schedule phenindamine hydrogen tartrate under HS 29339920. SMILES: CN1CCC2=C(C1)C(C3C2CCCC3)C4CCCCC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.